US58463J3041 - REIT

**MPW** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 128 industry peers in the **Diversified REITs** industry. **MPW** has only an average score on both its financial health and profitability. **MPW** does not seem to be growing, but still is valued expensively. Finally **MPW** also has an excellent dividend rating.

In the past year **MPW** has reported negative net income.

In the past year **MPW** had a positive cash flow from operations.

Of the past 5 years **MPW** 4 years had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **-0.18%**, **MPW** is doing worse than **63.71%** of the companies in the same industry.

Looking at the **Return On Equity**, with a value of **-0.42%**, **MPW** is doing worse than **64.52%** of the companies in the same industry.

With a **Return On Invested Capital** value of **2.41%**, **MPW** perfoms like the industry average, outperforming **45.16%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **MPW** is in line with the industry average of **2.99%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.18% | ||

ROE | -0.42% | ||

ROIC | 2.41% |

ROA(3y)3.44%

ROA(5y)4.87%

ROE(3y)8.03%

ROE(5y)10.33%

ROIC(3y)4.13%

ROIC(5y)4.16%

In the last couple of years the **Operating Margin** of **MPW** has declined.

In the last couple of years the **Gross Margin** of **MPW** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 40.95% | ||

PM (TTM) | N/A | ||

GM | 96.65% |

OM growth 3Y-1.5%

OM growth 5Y-2.31%

PM growth 3Y10.23%

PM growth 5Y7.37%

GM growth 3Y-0.16%

GM growth 5Y-0.36%

Based on the Altman-Z score of **0.32**, we must say that **MPW** is in the distress zone and has some risk of bankruptcy.

Looking at the **Debt to Equity ratio**, with a value of **1.23**, **MPW** is in line with its industry, outperforming **44.35%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.23 | ||

Debt/FCF | N/A | ||

Altman-Z | 0.32 |

ROIC/WACC0.49

WACC4.91%

A Quick Ratio of **2.13** indicates that **MPW** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.13 | ||

Quick Ratio | 2.13 |

The earnings per share for **MPW** have decreased strongly by **-103.37%** in the last year.

Measured over the past years, **MPW** shows a quite strong growth in **Earnings Per Share**. The EPS has been growing by **11.77%** on average per year.

Looking at the last year, **MPW** shows a very negative growth in **Revenue**. The Revenue has decreased by **-12.53%** in the last year.

EPS 1Y (TTM)-103.37%

EPS 3Y20.37%

EPS 5Y11.77%

EPS growth Q2Q-48.65%

Revenue 1Y (TTM)-12.53%

Revenue growth 3Y21.78%

Revenue growth 5Y16.97%

Revenue growth Q2Q-12.97%

Based on estimates for the next years, **MPW** will show a decrease in **Revenue**. The Revenue will decrease by **-3.78%** on average per year.

EPS Next Y-70.82%

EPS Next 2Y-24.6%

EPS Next 3Y-15.45%

EPS Next 5YN/A

Revenue Next Year-14.75%

Revenue Next 2Y-8.79%

Revenue Next 3Y-7.23%

Revenue Next 5Y-3.78%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The **Price/Earnings Ratio** is negative for **MPW**. In the last year negative earnings were reported.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **MPW** indicates a rather cheap valuation: **MPW** is cheaper than 100.00% of the companies listed in the same industry.

When comparing the **Price/Forward Earnings** ratio of **MPW** to the average of the S&P500 Index (**21.38**), we can say **MPW** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 4.38 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 10.21 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-24.6%

EPS Next 3Y-15.45%

With a **Yearly Dividend Yield** of **16.67%**, **MPW** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.48**, **MPW** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 16.67% |

The dividend of **MPW** has a limited annual growth rate of **4.17%**.

Dividend Growth(5Y)4.17%

Div Incr Years10

Div Non Decr Years13

The earnings of **MPW** are negative and hence is the payout ratio. **MPW** will probably not be able to sustain this dividend level.

DP-2006.32%

EPS Next 2Y-24.6%

EPS Next 3Y-15.45%

**MEDICAL PROPERTIES TRUST INC**

NYSE:MPW (2/22/2024, 2:26:08 PM)

**3.735**

**-0.06 (-1.71%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.24B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 16.67% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 4.38 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.18% | ||

ROE | -0.42% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 40.95% | ||

PM (TTM) | N/A | ||

GM | 96.65% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.07

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.23 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.13 | ||

Quick Ratio | 2.13 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-103.37%

EPS 3Y20.37%

EPS 5Y

EPS growth Q2Q

EPS Next Y-70.82%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-12.53%

Revenue growth 3Y21.78%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y